Method of assessment | Number of responses (%) n=98 | Neurosurgical unit number (%) n=25 | Non-neurosurgical unit number (%) n=73 |
---|---|---|---|
INR/near patient INR | 57 (58%) | 10 (40%) | 47 (64%) |
Coagulation screen | 46 (47%) | 12 (48%) | 34 (47%) |
Liver function tests | 4 (4%) | 2 (8%) | 2 (3%) |
ROTEM or TEG | 4 (4%) | 2 (8%) | 2 (3%) |
Full blood count | 8 (8%) | 2 (8%) | 6 (8%) |
Clinical findings | 2 (2%) | 2 (8%) | 0 (0%) |
Platelets | 7 (7%) | 1 (4%) | 6 (8%) |
Fibrinogen/fibrin degradation product | 10 (10%) | 7 (28%) | 2 (3%) |
Activated partial thromboplastin time | 11 (11%) | 1 (4%) | 10 (14%) |
Partial Prothrombin time | 2 (2%) | 0 (0%) | 2 (3%) |
Prothrombin Time | 6 (6%) | 2 (8%) | 4 (5%) |
Other | 4 (4%) | 1 (4%) | 3 (4%) |
No further assessment required | 8 (8%) | 4 (16%) | 4 (5%) |
Other: haemoglobin, liaise with the on-call haematologist, intracellular calcium and arterial/venous blood gases.
Free text box used so any number of responses permitted. Total respondents=98.
INR, International normalised ratio; ROTEM, rotational thromboelastometry; TEG, thromboelastography.